Methicillin Resistant Staphylococcus Aureus Skin Infections

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Methicillin Resistant Staphylococcus Aureus Skin Infections trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingPhase 4

NCT06982105

Trimethoprim-sulfamethoxazole vs. Clindamycin for the Treatment of Children With Invasive MRSA Infections

The goal of this clinical trial is to learn if trimethoprim-sulfamethoxazole (TMP-SMX) works to treat invasive infections due to methicillin-resistant Staphyloc…

United States100 participantsStarted 2025-05-20

Treatment: Trimethoprim Sulfamethoxazole

All recent trials (51 shown)

CompletedPhase 4

NCT02572791

Staph Household Intervention for Eradication (SHINE)

The investigators propose a pragmatic comparative effectiveness trial evaluating several decolonization strategies in patients with Staphylococcus aureus infect…

United States835 participantsStarted 2015-10

Treatment: Chlorhexidine, Mupirocin

CompletedPhase 4

NCT06210594

Staph Intervention for Effective Local Defense

Indigenous persons experience a high burden of Staphylococcus aureus (SA) invasive disease and skin and soft tissue infections. SA carriage on the skin is facto…

United States78 participantsStarted 2024-04-01

Treatment: Mupirocin + Nozin + chlorhexidine gluconate, Education + Household supplies

Methicillin Resistant Staphylococcus Aureus Skin Infections

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Trimethoprim-sulfamethoxazole vs. Clindamycin for the Treatment of Children With Invasive MRSA Infections

All recent trials (51 shown)

Staph Household Intervention for Eradication (SHINE)

Staph Intervention for Effective Local Defense

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Trimethoprim-sulfamethoxazole vs. Clindamycin for the Treatment of Children With Invasive MRSA Infections

All recent trials (51 shown)

Staph Household Intervention for Eradication (SHINE)

Staph Intervention for Effective Local Defense

Short and Long Term Outcomes of Doxycycline Versus Trimethoprim-Sulfamethoxazole for Skin and Soft Tissue Infections Tre…

Comparative Analysis of Nemonoxacin and Other Anti-methicillin Resistant Staphylococcus Aureus (Anti-MRSA) Antimicrobial…

A Randomized Clinical Trial to Prevent Recurrent CA-MRSA Infection

Dalbavancin for the Treatment of Acute Bacterial Skin and Skin Structure Infections in Children, Known or Suspected to b…

Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care

Staphylococcus Aureus Toxoids Phase 1-2 Vaccine Trial

Methicillin-resistant Staphylococcus Aureus (MRSA) Skin and Soft Tissue Infection (SSTI) Prevention in Military Trainees

Phase 2a Study of CG400549 for the Treatment of cABSSSI Caused by Methicillin-resistant Staphylococcus Aureus

Safety, Efficacy, and Pharmacokinetics (PK) of Daptomycin (MK-3009) in Japanese Pediatric Subjects With Complicated Skin…

Sivextro in Acute Bacterial Skin and Skin Structure Infection (ABSSSI) in Hospitalized Patients. A Global Observational…

Individualized vs. Household MRSA Decolonization

Comparison of Telavancin and Vancomycin for Complicated Skin and Skin Structure Infections With a Focus on Methicillin-r…

Comparison of Telavancin and Vancomycin for Complicated Skin and Skin Structure Infections With a Focus on Methicillin-r…

Direct Antibiotic Delivery of Cefazolin Into Soft Tissue Infections Using Subcutaneous Injection and Ultrasonic Dispersi…

Safety and Efficacy of BAY1192631 in Japanese Patients With Methicillin-resistant Staphylococcus Aureus (MRSA) Infection…

Daptomycin Versus Vancomycin in Participants With Skin Infections Due to MRSA

GSK1322322 Versus Linezolid in the Treatment of Acute Bacterial Skin and Skin Structure Infection

Delafloxacin vs Vancomycin and Aztreonam for the Treatment of Acute Bacterial Skin and Skin Structure Infections